On the path to a science of patient input

Science Translational Medicine

Volumn 8, Issue 336, 2016, Pages

  Anderson, Margaret ^a   McCleary, K Kimberly ^a  

^a FasterCures   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HUMAN; MEDICAL DEVICE; PATIENT CARE; PATIENT PARTICIPATION; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC-PRIVATE PARTNERSHIP; RESOURCE MANAGEMENT; REVIEW; RISK ASSESSMENT; STANDARDIZATION; TRANSLATIONAL RESEARCH; BIOMEDICAL ENGINEERING; MEDICAL RESEARCH;

BIOMEDICAL ENGINEERING; BIOMEDICAL RESEARCH; HUMANS; PATIENT PREFERENCE; PATIENT-CENTERED CARE;

EID: 84964911820     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf6730     Document Type: Review

References (25)

1. L. Stinson, IBM's got a plan to bring design thinking to big business. WIRED 21 January 2016; www.wired.com/2016/01/ibms-got-a-plan-to-bring-design-thinking-to-big-business.
2. M. Anderson, K. K. McCleary, From passengers to co-pilots: Patient roles expand. Sci. Transl. Med. 7, 291fs25 (2015).
3. J. A. Zachman, Zachman Framework (Zachman International, 2008); www.zachman.com/about-the-zachman-framework.
4. PG Engagement across the Research & Development Continuum (Clinical Trials Transformation Initiative, 2015); www.ctti-clinicaltrials.org/what-we-do/investigationalplan/patient-groups.
5. Medical Device Innovation Consortium (MDIC) patientcentered benefit-risk project report: A framework for incorporating information on patient preferences regarding benefit and risk into regulatory assessments of new medical technology (MDIC, St. Louis Park, MN, 2015); http://mdic.org/wp-content/uploads/2015/05/MDIC-PCBR-Framework-Web1.pdf.
6. L. Frank, L. Forsythe, L. Ellis, S. Schrandt, S. Sheridan, J. Gerson, K. Konopka, S. Daugherty, Conceptual andpractical foundations of patient engagement in research at the patient-centered outcomes research institute.Qual. Life Res.24, 1033-1041 (2015).
7. PCORI Methodology Standards (Patient-Centered Outcomes Research Institute, 2013); www.pcori.org/research-results/research-methodology/pcori-methodology-standards.
8. The Research Acceleration and Innovation Network (FasterCures,2016); http://train.fastercures.org/.
9. RARE Toolkits, (Global Genes, Aliso Viejo, CA, 2016); https://globalgenes.org/toolkits.
10. K. Schneeman, Patient engagement in medical R&D: Navigating the "teen years" (FasterCures, 3 March 2016); http://fastercures.tumblr.com/post/140402836399/patientengagement-in-medical-rd-navigating-the.
11. NQF to develop national standards, measurement for patient decision aids (National Quality Forum, 2016); www.qualityforum.org/News-And-Resources/Press-Releases/2016/NQF-to-Develop-National-Standards,-Measurement-for-Patient-Decision-Aids.aspx.
12. The voice of the patient: A series of reports from FDA's Patient-FocusedDrugDevelopment Initiative (FDA, 2015); www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm368342.htm.
13. Externally-led patient-focused drug development meetings (FDA, 2015); www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm453856.htm.
14. K. K. McCleary, S. Mayberry, Expanding the science of patient input: Building smarter patient registries (FasterCures, Washington, DC, 2016); www.fastercures.org/assets/Uploads/PDF/Patient-Registries.pdf.
15. M. Carlson Delogne, PatientsLikeMe and the FDA sign research collaboration agreement (PatientsLikeMe, 2015); http://news.patientslikeme.com/press-release/patientslikemeand-fda-sign-research-collaboration-agreement.
16. PCORnet, the National Patient-Centered Clinical Research Network; http://pcornet.org.
17. Precision Medicine Initiative Cohort Program-Frequently asked questions (National Institutes of Health, 2016); www.nih.gov/precision-medicine-initiative-cohort-program/precisionmedicine-initiative-cohort-program-frequently-asked-questions.
18. V. I. Prescription Drug User Fee Act, Fiscal Years 2018-2022 (FDA, Washington, DC, 2016); www.fda.gov/ForIndustry/UserFees/PrescriptionDrugUserFee/ucm446608.htm.
19. FDA, 2016-2017 Strategic Priorities: Center for Devices and Radiological Health (FDA, 2016); www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHVisionandMission/UCM481588.pdf.
20. FDA, Duchennemuscular dystrophy and related dystrophinopathies: Developing drugs for treatment-draft guidance for industry (FDA, Washington, DC, 2015); www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/UCM450229.pdf.
21. European Patients'Academy onTherapeutic InnovationTraining Course, (EUPATI, Germany, 2015); www.patientsacademy.eu/index.php/en/edu.
22. R. Hohman, M. Shea, M. Kozak, S. Roberts, J. Allen, E. Sigal, Regulatory decision-making meets the real world. Sci. Transl. Med. 7, 313fs46 (2015).
23. Reagan-Udall Foundation, Big data for patients (FDA, 2015); www.reaganudall.org/our-work/building-scientific-capacity/bd4p/.
24. E. M. Perfetto, E. M. Oehrlein, Assessing meaningful patient engagement in drug development: A definition, framework, and rubric (University of Maryland Center of Excellence in Regulatory Science and Innovation, 2015); www.pharmacy.umaryland.edu/media/SOP/wwwpharmacyumarylandedu/centers/cersievents/pfdd/mcersi-pfdd-framework-rubric.pdf.
25. Patient-Centered Outcomes Research Institute Evaluation Framework 2.0 (Patient-Centered Outcomes Research Institute, 2015); www.pcori.org/sites/default/files/PCORIEvaluation-Framework-2.0.pdf.